Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

152
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
152
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

390
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
390
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

292
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
292
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments.

Biometrics·2026
Same author

SEMIPARAMETRIC ANALYSIS OF INTERVAL-CENSORED DATA SUBJECT TO INACCURATE DIAGNOSES WITH A TERMINAL EVENT.

The annals of applied statistics·2026
Same author

DYNAMIC CLASSIFICATION OF LATENT DISEASE PROGRESSION WITH AUXILIARY SURROGATE LABELS.

The annals of applied statistics·2026
Same author

Asymptotic Inference for Multi-Stage Stationary Treatment Policy with Variable Selection.

Journal of machine learning research : JMLR·2026
Same author

Data fusion methods for the heterogeneity of treatment effect and confounding function.

Bernoulli : official journal of the Bernoulli Society for Mathematical Statistics and Probability·2026
Same author

Leveraging precision medicine analytics to optimize inflammation reduction and enhance physical function in older adults.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Sep 15, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K

Simultaneous Feature Selection for Optimal Dynamic Treatment Regimens.

Mochuan Liu1, Yuanjia Wang2, Donglin Zeng3

  • 1Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Statistics in Medicine
|July 15, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces L1 multistage ramp loss (L1-MRL) learning for dynamic treatment regimens (DTRs). The method simultaneously optimizes treatment decisions and selects relevant features across all stages, improving precision medicine applications.

Keywords:
decision‐makingdynamic treatment regimensgroup lassoramp loss functionvariable selection

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

913

Related Experiment Videos

Last Updated: Sep 15, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

913

Area of Science:

  • Biostatistics
  • Machine Learning
  • Precision Medicine

Background:

  • Dynamic Treatment Regimens (DTRs) are crucial for personalized medicine, tailoring treatments to patient characteristics over time.
  • Current DTR methods often use sequential approaches, leading to accumulated errors in feature selection across stages.
  • Efficient feature selection is vital for developing parsimonious and reliable DTRs.

Purpose of the Study:

  • To develop a novel framework for simultaneous optimization of DTRs and feature selection across all stages.
  • To address limitations of existing sequential methods in handling feature importance across multiple decision points.
  • To enhance the reliability and practicality of learning optimal DTRs in precision medicine.

Main Methods:

  • Proposed L1 multistage ramp loss (L1-MRL) learning framework for simultaneous DTR optimization and variable selection.
  • Utilized a single multistage ramp loss function for estimating optimal DTRs across all stages.
  • Implemented a group Lasso-type penalty for identifying features important across any stage.

Main Results:

  • Theoretically demonstrated the consistency and oracle property of the proposed L1-MRL estimator.
  • Simulation studies showed L1-MRL performs comparably to or better than existing DTR methods with variable selection.
  • Applied the method to electronic health record (EHR) data for type 2 diabetes (T2D) patients.

Conclusions:

  • L1-MRL learning offers a robust approach for developing effective DTRs with simultaneous feature selection.
  • The method overcomes limitations of sequential approaches, reducing false discovery errors.
  • This framework advances precision medicine by enabling more reliable and parsimonious treatment strategies.